Clearbridge Health (1H3) Fundamentals 2026 — Revenue Analysis | SniperIQ
Clearbridge Health (1H3) is a SG-listed Healthcare company in Medical - Diagnostics & Research with a market capitalization of S$9M, trading at S$0.00 on the SES. This SniperIQ fundamentals page covers Clearbridge Health's valuation, profitability (net margin -129.4%), revenue (S
0M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Market CapS$9M
Net Margin-129.4%
Revenue (FY25)S
0M
Full research coverage
8-Quarter Revenue & Margin Trend
Debt Maturity & Coverage
Peer Valuation Comparison
Free Cash Flow & Owner Earnings
AI Signal + Institutional Flow
DCF Valuation Model
Frequently Asked Questions
What is Clearbridge Health's market cap?
Clearbridge Health (1H3) has a market capitalization of approximately S$9M, trading at S$0.00 on the SES. Market cap moves with the live share price.
What is Clearbridge Health's P/E ratio?
Clearbridge Health's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Clearbridge Health?
Clearbridge Health runs a net profit margin of -129.4%, a gross margin of 50.1%, and an operating margin of -13.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Clearbridge Health generate?
Clearbridge Health reported revenue of S
0M for fiscal year 2025, with net income of -S
3M and earnings per share (EPS) of -0.0039. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Clearbridge Health pay a dividend?
Clearbridge Health does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Clearbridge Health financially healthy?
Clearbridge Health carries a debt-to-equity ratio of 0.42x and a current ratio of 1.51x, with a market beta of 0.11. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Clearbridge Health a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Clearbridge Health (1H3) the key facts are: market cap S$9M, revenue S
0M, 52-week range 0.001-0.005. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Clearbridge Health's full fundamentals live
Get Clearbridge Health's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.